Jun 25 |
FDA expands Fractyl endoscopy trial to include untreated diabetes patients
|
Jun 25 |
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
|
Jun 24 |
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
|
Jun 23 |
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association...
|
May 29 |
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
|
May 20 |
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
|
May 14 |
Fractyl Health, Inc. (GUTS) Q1 2024 Earnings Call Transcript
|
May 13 |
Fractyl Health reports Q1 results
|
May 13 |
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
|
May 13 |
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
|